Skip to main
IVVD

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is positioned favorably in the biopharmaceutical sector, especially with its lead product PEMGARDA achieving emergency use authorization, which demonstrates regulatory validation and market readiness for its monoclonal antibody therapies. The company's engagement in a Phase 3 program (REVOLUTION) for VYD2311 is significant, as it could expand the target market substantially and provide evidence of mAb superiority over traditional mRNA vaccines, addressing a large population of immunocompromised individuals. Furthermore, the ongoing developments in next-generation antibody candidates and the potential revenue opportunities in the substantial COVID-19 vaccine market underscore Invivyd's prospects for growth in addressing viral infectious diseases.

Bears say

The analysis highlights fundamental concerns regarding Invivyd Inc's market potential, particularly due to the significant reduction in the efficacy of its leading monoclonal antibody therapy, PEMGARDA, against the omicron variant as evidenced by a 200-fold decline in activity observed during the STAMP trial. Furthermore, the company faces a challenging commercial landscape characterized by plummeting vaccination rates for COVID-19 and influenza, which may diminish demand for its therapies targeting immunocompromised individuals. As vaccine hesitancy persists and overall market opportunities narrow, Invivyd's financial outlook appears increasingly precarious.

Invivyd Inc (IVVD) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Mar 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.